Japanese health data study reveals Real-World use of eye drug
NCT ID NCT06929143
First seen Jan 07, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study reviews existing health records from about 3000 people in Japan who received aflibercept 8 mg injections for two eye conditions that cause vision loss. Researchers will describe the patients' characteristics and how the drug was used over one year. No new treatments or visits are involved—only data already collected from routine care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bayer
Osaka, 5300001, Japan
Conditions
Explore the condition pages connected to this study.